 |
|
Researchers identify 4 genetic hotspots associated with psoriasis
January 27, 2009Study looked at millions of genetic mutations for link to skin disease
SALT LAKE CITY - A genomewide scan of millions of genetic mutations has revealed four new DNA "hotspots" that affect the risk for psoriasis, a national group of researchers led by the University of Michigan and including several from the University of Utah School of Medicine has shown in a just-published study.
Appearing Jan. 25 in Nature Genetics online, the study also confirmed that two other previously identified DNA sites, discovered by researchers at the University of Utah and Celera Group, have a high association with psoriasis, an automimmune disease that can affect the joints and cause sore, itchy patches of skin in an estimated 7.5 million people in the United States.
The study was led by James T. Elder, M.D., Ph.D., a dermatologist who heads a group at the University of Michigan with long-standing interest in and an international reputation for its work in the genetics of psoriasis, and Goncalo Abecasis, Ph.D., a biostatistician at the University of Michigan. They elected to make the study a collaboration with researchers at Washington University in St. Louis and the University of Utah. Gerald G. Krueger, M.D., professor of dermatology and Benning Presidential Endowed Chair holder at the U of U, and his colleague Kristina Callis Duffin, M.D., assistant professor of dermatology, led the Utah portion of the study.
Krueger and Duffin said the study is important for several reasons.
"First, it shows the efficacy of using this (genomewide) approach to further understand this disease," Krueger said. "Second, it confirmed findings we reported in 2007 of polymorphisms (mutations) in the IL-12/23 pathways. Third, we now find a third polymorphism in this same cluster, IL-23A. Fourth, a treatment that knocks down IL-12 and IL-23 recently has been shown to be a very effective treatment for psoriasis."
This, plus the clustering of polymorphisms the IL-12/23 pathways, makes it apparent that this pathway is important to the pathogenesis of psoriasis, according to Krueger.
The researchers took advantage of a new technology called genomewide association studies (GWAS). At the heart of this is selecting from the more than10 million polymorphisms (mutations) in the human genome a group of polymorphisms that are predicted to be informative of association with disease, in this case psoriasis. The platform used in this experiment contained 438,670 polymorphisms. To assess for psoriasis-associated polymorphisms each of the 1,359 subjects with psoriasis and a control group of 1,400 people without the disease had their DNA probed for each of the 438,670 polymorphisms. After identifying 18 DNA sites with the highest associations with psoriasis, the researchers expanded the study to include 5,048 people with psoriasis and 5,051 without the disease. From that, the researchers identified seven potential genetic hotspots for psoriasis.
Three of those sites-IL-12B, IL-23R and IL-13 -were first identified in earlier studies by Krueger and other University of Utah and Celera Group researchers. A third gene, HLA-C, has the strongest association with psoriasis and has been found numerous times by many investigators. Most recently, the Elder group showed this association appears to be linked to an allele of HLA-C called *0602, and the latest study confirms this, once again. Three new polymorphisms reported in the Nature Genetics study-IL-23A, TNFAIP3, and TNI1-had not been linked to the skin and joint disorder, and in addition there has been confirmation of IL-13 and a closely linked partner IL-4.
The researchers concluded that IL-12B and IL-23-R encode proteins that bind to IL-23A and that mutations in any of those genes may predispose people to immune responses that lead to psoriasis. The study also showed that genetic signals from two regulatory elements, TNFAIP3 and TNI1, of TNF-alpha, may be faulty regulating the TNF-alpha induced inflammation of psoriasis and psoriatic arthritis. Polymorphisms of TNFAIP3 and TNI1 are also associated with two other autoimmune diseases, lupus and rheumatoid arthritis.
The number of DNA sites discovered to have strong associations with psoriasis has increased from one to 10 in the past 18 months. But many more polymorphisms probably are associated with the disease, according to Krueger. He believes the number that ultimately will be associated with psoriasis could be close to 300.
Once all the gene mutations connected to psoriasis have been indentified, researchers may be able to develop a genetic profile to predict the risk of developing the disease, the type of disease, and response to treatment. Krueger expects that quite soon a gene chip containing psoriasis-associated genetic mutations will be available to aid in the study of the disease.
University of Utah Health Sciences
The study was led by James T. Elder, M.D., Ph.D., a dermatologist who heads a group at the University of Michigan with long-standing interest in and an international reputation for its work in the genetics of psoriasis, and Goncalo Abecasis, Ph.D., a biostatistician at the University of Michigan. They elected to make the study a collaboration with researchers at Washington University in St. Louis and the University of Utah. Gerald G. Krueger, M.D., professor of dermatology and Benning Presidential Endowed Chair holder at the U of U, and his colleague Kristina Callis Duffin, M.D., assistant professor of dermatology, led the Utah portion of the study.
Krueger and Duffin said the study is important for several reasons.
"First, it shows the efficacy of using this (genomewide) approach to further understand this disease," Krueger said. "Second, it confirmed findings we reported in 2007 of polymorphisms (mutations) in the IL-12/23 pathways. Third, we now find a third polymorphism in this same cluster, IL-23A. Fourth, a treatment that knocks down IL-12 and IL-23 recently has been shown to be a very effective treatment for psoriasis."
This, plus the clustering of polymorphisms the IL-12/23 pathways, makes it apparent that this pathway is important to the pathogenesis of psoriasis, according to Krueger.
The researchers took advantage of a new technology called genomewide association studies (GWAS). At the heart of this is selecting from the more than10 million polymorphisms (mutations) in the human genome a group of polymorphisms that are predicted to be informative of association with disease, in this case psoriasis. The platform used in this experiment contained 438,670 polymorphisms. To assess for psoriasis-associated polymorphisms each of the 1,359 subjects with psoriasis and a control group of 1,400 people without the disease had their DNA probed for each of the 438,670 polymorphisms. After identifying 18 DNA sites with the highest associations with psoriasis, the researchers expanded the study to include 5,048 people with psoriasis and 5,051 without the disease. From that, the researchers identified seven potential genetic hotspots for psoriasis.
Three of those sites-IL-12B, IL-23R and IL-13 -were first identified in earlier studies by Krueger and other University of Utah and Celera Group researchers. A third gene, HLA-C, has the strongest association with psoriasis and has been found numerous times by many investigators. Most recently, the Elder group showed this association appears to be linked to an allele of HLA-C called *0602, and the latest study confirms this, once again. Three new polymorphisms reported in the Nature Genetics study-IL-23A, TNFAIP3, and TNI1-had not been linked to the skin and joint disorder, and in addition there has been confirmation of IL-13 and a closely linked partner IL-4.
The researchers concluded that IL-12B and IL-23-R encode proteins that bind to IL-23A and that mutations in any of those genes may predispose people to immune responses that lead to psoriasis. The study also showed that genetic signals from two regulatory elements, TNFAIP3 and TNI1, of TNF-alpha, may be faulty regulating the TNF-alpha induced inflammation of psoriasis and psoriatic arthritis. Polymorphisms of TNFAIP3 and TNI1 are also associated with two other autoimmune diseases, lupus and rheumatoid arthritis.
The number of DNA sites discovered to have strong associations with psoriasis has increased from one to 10 in the past 18 months. But many more polymorphisms probably are associated with the disease, according to Krueger. He believes the number that ultimately will be associated with psoriasis could be close to 300.
Once all the gene mutations connected to psoriasis have been indentified, researchers may be able to develop a genetic profile to predict the risk of developing the disease, the type of disease, and response to treatment. Krueger expects that quite soon a gene chip containing psoriasis-associated genetic mutations will be available to aid in the study of the disease.
University of Utah Health Sciences
Psoriasis Current Events and Psoriasis News RSSCurry-cure? Spicing up the effectiveness of a potential disease-fighter
Scientists are reporting development of a nano-size capsule that boosts the body's uptake of curcumin, an ingredient in yellow curry now being evaluated in clinical trials for treatment of several diseases.
Skin-disease patients show brain immunity to faces of disgust
People with psoriasis - an often distressing dermatological condition that causes lesions and red scaly patches on the skin - are less likely to react to looks of disgust by others than people without the condition, new research has found.
Gene variation is 'major genetic determinant of psoriasis'
A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, University of Utah medical researchers show in a new study.
Drug rescues memory lost to Alzheimer's disease
A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer's symptoms.
Post-transplant combo can replace toxic immune-suppressing drugs in monkeys
Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects.
Psoriasis associated with cardiovascular disease and increased mortality
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death.
Scientists discover new genetic immune disorder in children
Your immune system plays an important function in your health-it protects you against viruses, bacteria, and other toxins that can cause disease.
Study finds unexpected bacterial diversity on human skin
The health of our skin - one of the body's first lines of defense against illness and injury - depends upon the delicate balance between our own cells and the millions of bacteria and other one-celled microbes that live on its surface.
Vitamin D may halt lung function decline in asthma and COPD
Vitamin D may slow the progressive decline in the ability to breathe that can occur in people with asthma as a result of human airway smooth muscle (HASM) proliferation, according to researchers at the University of Pennsylvania.
Home UVB therapy for psoriasis as effective and safe as hospital treatment
For patients with psoriasis, treatment with ultraviolet B (UVB) at home is as effective and as safe as conventional hospital based phototherapy, concludes a study published on bmj.com today.
More Psoriasis Current Events and Psoriasis News Articles
 |
Healing Psoriasis: The Natural Alternative by John Pagano (Author) A leading researcher shares natural remedies for psoriasis According to the National Psoriasis Foundation, at least seven million people in the U.S. and more than 100 million worldwide suffer from this chronic skin disease. This book outlines Dr. Pagano's natural, drug-free treatment regimen that can alleviate, control, and even heal psoriasis without steroid creams, tar baths, injections, or ultraviolet treatments. Healing Psoriasis outlines a healthy diet and lifestyle and includes case histories, photos, recipes, and a chapter on eczema. John O. A. Pagano, DC (Englewood Cliffs, NJ), is a chiropractic physician who has conducted psoriasis research for more than 40 years. He has been a featured guest on CNBC, ABC, and Health Talk with Dr. Ronald Hoffman, and... |
 |
Loma Lux Homeopathic Medicine, Psoriasis, 8 fl oz (237 ml) by Loma Lux For relief from the scaling, itching and redness of Psoriasis and Seborrhea. Take orally. 2% Alcohol. Dermatologist Steven A. Smith, MD, developed the Loma Lux Psoriasis formula & has proven its effectiveness in treating thousands of patients for psoriasis and seborrheic dermatitis. Get relief from scaling, flaking, redness, pain and itching with Loma Lux Psoriasis. I spent hundreds of dollars on creams from the doctor; nothing worked. A miracle came in Loma Lux Psoriasis! before the first month was up I noticed a big difference in my psoriasis. My skin cleared with continued use. Loma Lux is dedicated to promote worldwide health and wholeness using natural, low dose, low side effect treatments, bringing freedom from chronic diseases. |
 |
Your Healing Diet: A Quick Guide to Reversing Psoriasis and Chronic Diseases with Healing Foods by Deirdre Earls RD LD (Author) 'Your Healing Diet: A Quick Guide to Reversing Psoriasis and Chronic Diseases with Healing Foods' is a handbook written by Deirdre Earls, RD, LD, to make it faster and easier to eat in a way that enables the body to heal itself. A short guidebook which was designed to be very user-friendly, it also explains how food can create and reverse disease. In essense, the book distills common threads of success amongst several healing diets like Macrobiotics, Raw Foods, Alkalizing, Cancer and Heart Disease Prevention, Anti-Aging and Anti-inflammatory Diets. Then it demonstrates how you can easily incorporate healing habits into your busy lifestyle. Special segments discuss healing principles and what to expect when healing naturally. Whether or not you're an Austinite, you'll also find... |
 |
Adovia Natural Dead Sea Mud Soap - Great for Eczema, Psoriasis or Acne! by Adovia Mineral Skin Care Our All Natural Black Mud Soap contains a unique combination of Dead Sea minerals derived from Dead Sea Mud. This effective mud soap removes dirt and cleanses your skin, while simultaneously infusing it with minerals essential to keeping your skin hydrated and moisturized. Our Dead Sea mud soap is enriched with century old Dead Sea mud, leaving your skin cleansed and nourished. As more people are learning about the healing and beauty effects of black mud from The Dead Sea, this soap is becoming a very popular choice for skin care conscious people. |
 |
The Psoriasis Cure: A Drug-Free Guide to Stopping and Reversing the Symptoms of Psoriasis by Lisa LeVan (Author) This book offers hope for those who suffer from this debilitating systemic disease. Beyond causing scaly red patches on the skin, psoriasis can result in aching joints, listlessness, and arthritis. Featuring a nutritional approach to treatment, this book teaches the patient to eliminate allergic reactions and to add specific supplements to the diet. |
 |
Mg 217 Intensive Strength Medicated Tar Ointment for Psoriasis - 3.8 Oz by Mg 217 Mg 217 Intensive Strength Medicated Tar Ointment for Psoriasis is specially formulated to control the itching, redness and scaling from skin psoriasis. |
 |
Psoriasis, Healing from the Inside Out by Heather J. Ferris (Author) An important book for people with psoriasis and other conditions, who feel controlled by their diseases. This book addresses issues of the body, mind and spirit. It also provides practical techniques and opportunities to reflect on individual situations and to make the necessary changes. |
 |
Oxipor VHC Psoriasis Lotion, Coal Tar Solution, 4-Ounce Bottle by Oxipor Oxipor psoriasis lotion controls itching, and relieves redness and scaling. |
 |
Psoriasis: Everything You Need to Know (Your Personal Health) by Dr Richard G.B. Langley (Author) Helpful advice for relief of a chronic condition that affects millions. Psoriasis is a chronic inflammatory, non-contagious skin disease. Characterized by itchy, thick and raised red areas of skin covered with silvery-white scales, psoriasis affects 1 in 50 adults. This affliction makes it one of the world's most common skin disorders. Appearing at any age, it can affect relationships, the ability to work and to enjoy leisure activities. Psoriasis is a straightforward book about an all too common problem. The information is presented in clear, understandable terms for non-medical readers, covering: - Causes - Psychosocial effects - Diagnosis - Treatment options - Psoriatic arthritis - Psoriasis in children. Psoriasis includes line drawings, case studies, a... |
 |
Psoriasis: The Real Way Out: A Self-Education Guide to Complete Natural Healing by Jerry G. Scott R.N.C. (Author) This is a book for the determined, not for the quick fix crowd. A clear understanding of the underlying causes of psoriasis is presented, one that flies in the face of current drug-oriented treatments, nevertheless one that recognizes the causes and alleviation of psoriasis that have been known for decades. Leading edge strategies are also revealed, and resources are listed. The book is blunt, and does not coddle the reader. Rather, it requires participation if the reader is to be healed of the condition, and very specific solutions are offered in a comprehensive plan of action. Uniquely, the author offers his personal help when readers are registered through links that are provided in the book. |
| © 2009 BrightSurf.com |